Ayurvedic Management Of Arma WSR to Pterygium

Not yet recruiting

Conditions: Conjunctival degenerations and deposits. Ayurveda Condition: PRASTARI-ARMA,

Registration Number: CTRI/2025/05/086180

Lead Sponsor: Dr Divya Tukaram Moodi

Brief Summary: *Arma*is one among *Shuklagataroga* explained by *Acharya Sushrutha* and *Acharya Vagbhata.* It is defined as *IYARTI GACCHATHI ITI ARMA*. Which means gradually spreading of fleshy growth occurring in *Shukla mandala.* The *Lakshanas* of *Arma* can be correlated with signs and symptoms of Pterygium in modern ophthalmology. Pterygium is a wing shaped fold of conjunctiva encroaching upon cornea from either side within interpalpebral fissure. Pathologically Pterygium is an elastotic degeneration of subconjunctival tissue. In a population-based study from rural central India, prevalence of pterygium increased from 6.7±0.8% in the age group from 30–39 years to 25.3±2.1% in the age group of 70–79 years. The epidemiological studies around worldwide have shown that prevalence rates ranges from 0.3% to 37.46%.

Pterygium is more common in people living in hot climate, and in those who work outdoors. Thus it is considered as a response to prolonged effect of environmental factors such as exposure to sunlight (UV rays), dry heat, high wind and abundance of dust. Asymptomatic nature of the disease and non-availability of medical treatment are the main hurdles in management. Meanwhile it fails to decrease the complication such as development of cyst, ongoing diplopia, Dry eye, scleral or corneal melting. it not only affects the outlook of the patient, but also affects refractive astigmatism which can have significant impact on vision in advanced stage due to the invasion of cornea.

In modern science surgical treatment is only satisfactory approach. Recurrence after surgical excision is common and recurred lesions grow more aggressively than primary lesions. Cost of Surgery is too expensive. Hence to overcome the lacuna in modern therapeutics the present clinical study has been taken up. Therefore an alternative treatment which is safe, devoid of complication, easy to administer and cost effective is need for hour.

In Classics different treatment modalities are explained for the management of *Arma* mainly *Lekhana, Chedhana, Anjana. Arma* is a type of *Mamsavriddhi* (muscle like growth) hence *Acharyas* have indicated as *Chedana sadya* and *Lekhana sadya vyadhi*. *Marichanjana*and *Darvadyanjana*both are mentioned in *Basavarajeeyam, Netraroghadhikara.* Hence an attempt is made to compare the efficacy of *Marichanjana* and *Darvadyanjana* in management of *ARMA*

**NULL HYPOTHESIS**

**H0** - *Marichanjana* is not effective in management of *Arma* with special reference to pterygium.

**ALTERNATE HYPOTHESIS**

**H1** - *Marichanjana* Is more effective than *Darvadyanjana* i in management *Arma* with special reference to pterygium

**H2** - *Marichanjana* is less effective than *Darvadyanjana* in management of *Arma* with special reference to pterygium.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 40

Inclusion Criteria

1 Patients between age group of 30 years to 70 years.
2 Clinical features as per classics.
3 Patients with Pterygium that is limited to limbus.
4 Controlled Diabetic patients 5 Controlled HTN Patients.

Exclusion Criteria

1 Arma with any other ocular pathology.
2 Pseudo pterygium 3 Those contraindicated for Anjana karma.
4 Pregnant women and Lactating mother.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1 Pictorial presentation	60 Days
2 Length	60 Days
3 Thickness	60 Days

Secondary Outcome Measures

Name	Time	Method
1 Foriegn body sensation	2 Redness

Trial Locations

Locations (1): Government Ayurveda Medical College
🇮🇳
Bangalore, KARNATAKA, India
Government Ayurveda Medical College
🇮🇳Bangalore, KARNATAKA, India
Dr Divya Tukaram Moodi
Principal investigator
9686469722
divyatm21@gmail.com